Clinical Trial Update: Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)

View source ↗

Summary

This document provides an update on post-trial access for Nipocalimab in participants with warm autoimmune hemolytic anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Warm Autoimmune Hemolytic Anemia

Drugs mentioned

• Nipocalimab (nipocalimab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Warm Autoimmune Hemolytic Anemia | Status: TEMPORARILY_NOT_AVAILABLE